Known for its innovative and interdisciplinary approach to education at both the graduate and undergraduate levels, the University of Alabama at Birmingham, a part of the University of Alabama System, is an internationally renowned research university and academic medical center with over $700 million in research awards annually, as well as Alabama’s largest single employer, with some 26,000 employees, and has an annual economic impact exceeding $7.15 billion on the state. The pillars of UAB’s mission include education, research, innovation and economic development, community engagement, and patient care. Learn more at www.uab.edu.
BioHorizons, Inc., a majority-owned subsidiary of Henry Schein, Inc. (NASDAQ:HSIC), is a leading dental implant and biologics company located in Birmingham, Alabama. The company has a broad product offering, including dental implants, surgical planning software and tissue regeneration solutions for the replacement of missing teeth. BioHorizons products are available in 85 markets around the world. For more information, visit biohorizons.com.
Southern Research is a nonprofit, translational scientific research organization with an 80-year legacy of moving science through drug discovery, drug development and environmental health.
This legacy includes helping shape modern cancer treatment practices by developing seven FDA-approved cancer drugs and co-creating a COVID-19 vaccine currently in clinical trials. These innovations are made possible because of our greatest assets, our people that move science every day at every level of Southern Research.